Frataxin gene of Friedreich's ataxia is targeted to mitochondria

被引：84
|
作者：
Priller, J
Scherzer, CR
Faber, PW
MacDonald, ME
Young, AB
机构：
[1] MASSACHUSETTS GEN HOSP,NEUROL SERV,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,BOSTON,MA
[3] MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,CHARLESTOWN,MA
来源：
ANNALS OF NEUROLOGY | 1997年 / 42卷 / 02期
关键词：
D O I：
10.1002/ana.410420222
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Friedreich's ataxia is caused by a triplet repeat expansion in intron 1, a noncoding region of the frataxin gene (X25). We have generated a chimeric gene composed of the frataxin gene fused with the green fluorescent protein (GFP) gene as a reporter. Transfection of the fusion construct into living COS cells revealed that the frataxin-GFP construct localizes to organelles that double-label with 8-(4'-chloromethyl) phenyl-2,3,5,6,11,12,14,15-octahydro-1H,4H,10H-13H-diquinolizino 8H-xanthylium chloride (CMXRos), a novel mitochondrial dye. Thus, frataxin appears to be a nuclear-encoded mitochondrial protein.
引用
收藏
页码：265 / 269
页数：5
相关论文
共 50 条
  • [21] Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin
    Musco, G
    Stier, G
    Kolmerer, B
    Adinolfi, S
    Martin, S
    Frenkiel, T
    Gibson, T
    Pastore, A
    STRUCTURE, 2000, 8 (07) : 695 - 707
  • [22] Frataxin levels in peripheral tissue in Friedreich ataxia
    Lazaropoulos, Michael
    Dong, Yina
    Clark, Elisia
    Greeley, Nathaniel R.
    Seyer, Lauren A.
    Brigatti, Karlla W.
    Christie, Carlton
    Perlman, Susan L.
    Wilmot, George R.
    Gomez, Christoper M.
    Mathews, Katherine D.
    Yoon, Grace
    Zesiewicz, Theresa
    Hoyle, Chad
    Subramony, Sub H.
    Brocht, Alicia F.
    Farmer, Jennifer M.
    Wilson, Robert B.
    Deutsch, Eric C.
    Lynch, David R.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (08): : 831 - 842
  • [23] Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia
    Becker, E
    Richardson, DR
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (01): : 1 - 10
  • [24] Friedreich's ataxia and frataxin: Molecular genetics, evolution and pathogenesis (Review)
    Palau, F
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (06) : 581 - 589
  • [25] Neurodegeneration in Friedreich's Ataxia: From Defective Frataxin to Oxidative Stress
    Gomes, Claudio M.
    Santos, Renata
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013
  • [26] Gene therapy for Friedreich Ataxia: evaluation of regulatory elements to control frataxin expression
    Huichalaf, C.
    Perfitt, T. L.
    Kuperman, A.
    Chen, X.
    Hirenallur-Shanthappa, D.
    Gooch, R.
    Kovi, R.
    Brenneman, K.
    Coskran, T.
    Franks, T.
    Monarksi, L.
    Whiteley, L.
    Bulawa, C.
    Pregel, M.
    Martelli, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A255 - A256
  • [27] Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia
    Anzovino, A.
    Lane, D. J. R.
    Huang, M. L-H
    Richardson, D. R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) : 2174 - 2190
  • [28] Friedreich Ataxia: rat ventricular myocytes deficient in frataxin have disrupted mitochondria and impaired metabolism
    de Obis, E.
    Mincheva, S.
    Ros, J.
    Tamarit, J.
    FEBS JOURNAL, 2012, 279 : 195 - 196
  • [29] Characterization of frataxin gene network in Friedreich's ataxia fibroblasts using the RNA-Seq technique
    Sanchez, Noelia
    Chapdelaine, Pierre
    Rousseau, Joel
    Raymond, Frederic
    Corbeil, Jacques
    Tremblay, Jacques P.
    MITOCHONDRION, 2016, 30 : 59 - 66
  • [30] Human recombinant erythropoietin increases frataxin in Friedreich ataxia
    Boesch, S.
    Sturm, B.
    Hering, S.
    Goldenberg, H.
    Scheiber-Mojdehkar, B.
    Poewe, W.
    MOVEMENT DISORDERS, 2007, 22 : S14 - S15
12345